Gelati - Not knowing you well I don't know if that was a cynical question or not. I would think the ownership of the technology is incidental to the medical know-how that developed it.
I actually think, without ever having spoken to potential end users, that it the the bias against foreign ( read: non American) medicine that is holding us back. Had this same technology been developed by an American University I think we would be much further along in the commercialization of Asepticsure.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.